Optimal conditions for the performance of a monocyte monolayer assay

Transfusion

Volumn 56, Issue 11, 2016, Pages 2680-2690

  Tong, Tik Nga ^a   Burke Murphy, Emeralda ^a   Sakac, Darinka ^a   Pendergrast, Jacob ^c   Cserti Gazdewich, Christine ^c   Laroche, Vincent ^d   Branch, Donald R ^a,b,c  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CITRATE DEXTROSE; BUFFER; EDETIC ACID; HEPARIN; RHESUS D ANTIBODY; ALLOANTIBODY; ANTICOAGULANT AGENT; OPSONIN;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD SAMPLING; BLOOD STORAGE; CELL ASSAY; CELL INTERACTION; CELL PH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; MALE; MONOCYTE MONOLAYER ASSAY; OPSONIZATION; PHAGOCYTOSIS; ROOM TEMPERATURE; STORAGE TEMPERATURE; TEMPERATURE; ADVERSE EFFECTS; BLOOD; BLOOD TRANSFUSION; ERYTHROCYTE; IMMUNOLOGY; MIDDLE AGED; MONOCYTE; PH; PROCEDURES; STANDARDS; TIME FACTOR; YOUNG ADULT;

ADULT; ANTICOAGULANTS; BLOOD PRESERVATION; BLOOD TRANSFUSION; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; ISOANTIBODIES; MALE; MIDDLE AGED; MONOCYTES; OPSONIN PROTEINS; PHAGOCYTOSIS; TEMPERATURE; TIME FACTORS; YOUNG ADULT;

EID: 84988280996     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13766     Document Type: Article

References (36)

1. Schanfield MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically significant antibodies in the laboratory. Prog Clin Biol Res 1980;43:305–23.
2. Hunt JS, Beck ML, Hardman JT, et al. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction. Am J Clin Pathol 1980;74:259–64.
3. Schanfield MS, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571–6.
4. Hunt JS, Beck ML, Wood GW. Monocyte-mediated erythrocyte destruction. A comparative study of current methods. Transfusion 1981;21:735–8.
5. Conley CL, Lippman SM, Ness PM, et al. Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med 1982;306:281–6.
6. Hunt JS, Beck ML, Tegtmeier GE, et al. Factors influencing monocyte recognition of human erythrocyte autoantibodies in vitro. Transfusion 1982;22:355–8.
7. Gallagher MT, Branch DR, Mison A, et al. Evaluation of reticuloendothelial function in autoimmune hemolytic anemia using an in vitro assay of monocyte-macrophage interaction with erythrocytes. Exp Hematol 1983;11:82–9.
8. Branch DR, Gallagher MT, Shulman IA, et al. Reticuloendothelial cell function in alpha-methyldopa-induced hemolytic anemia. Vox Sang 1983;45:278–87.
9. Alperin JB, Riglin H, Branch DR, et al. Anti-M causing delayed hemolytic transfusion reaction. Transfusion 1983;23:322–4.
10. Branch DR, Gallagher MT, Mison AP, et al. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes. Br J Haematol 1984;56:19–29.
11. Pérez D, Cohen DW, Shulman IA, et al. Rhesus Du incompatibility in a newborn without hemolytic disease: a possible role for the mononuclear phagocyte system in the benign clinical course. Vox Sang 1986;51:341–3.
12. Branch DR, Gallagher MT. Correlation of in vivo alloantibody significance or insignificance with an in vitro monocyte-macrophage phagocytosis assay. Br J Haematol 1986;62:783–5.
13. Zupanska B, Thompson E, Brojer E, et al. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96–101.
14. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.
15. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Trans Med Rev 1990;4:297–312.
16. Mendoza E, Gutgsell N, Temple JD, et al. Monocyte phagocytic activity in sickle cell disease. Acta Haematol 1991;85:199–201.
17. Lucas GF, Hadley AG, Nance SJ, et al. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993;33:484–7.
18. Żupańska B, Gronkowska A, Zimeski M. Comparison of activity of peripheral monocytes and splenic macrophages in the monocyte monolayer assay. Vox Sang 1995;68:241–2.
19. Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.
20. Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92–100.
21. Michelis FV, Branch DR, Scovell I, et al. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes. Transfusion 2014;54:681–90.
22. a allo-antibodies. Vox Sang 1987;53:228–30.
23. Fabron A Jr, Baleotti W Jr, de Mello AB, et al. Application of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients. Transfus Apher Sci 2004;31:29–35.
24. Hess JR. An update on solutions for red cell storage. Vox Sang 2006;91:13–9.
25. Purohit MK, Chakka SK, Scovell I, et al. Structure-activity relationships of pyrazole derivatives as potential therapeutics for immune thrombocytopenias. Bioorg Med Chem 2014;22:2739–52.
26. Rampersad GC, Suck G, Sakac D, et al. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells. Transfusion 2005;45:384–93.
27. Foo AH, Fletcher SP, Langler RF, et al. Structure-function studies for in vitro chemical inhibition of Fc gamma receptor-mediated phagocytosis. Transfusion 2007;47:290–8.
28. Lu FQ, Kang W, Peng Y, et al. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method. Transfusion 2011;51:2199–207.
29. Eckstein M, Zimmermann R, Roth T, et al. The effects on an overnight holding of whole blood at room temperature on haemoglobin modification and in vitro markers of red blood cell aging. Vox Sang 2015;108:359–67.
30. Dumont LJ, Cancelas JA, Maes LA, et al. Overnight, room temperature hold of whole blood followed by 42-day storage of red blood cells in additive solution-7. Transfusion 2015;55:485–90.
31. Dzik W, Neckers L. Mononuclear cell-surface antigens during storage of banked blood. Transplantation 1984;38:67–71.
32. Akriotis V, Biggar WD. The effects of hypothermia on neutrophil function in vitro. J Leukoc Biol 1985;37:51–61.
33. Bennett S, Por SB, Stanley ER, et al. Monocyte proliferation in a cytokine-free, serum-free system. J Immunol Methods 1992;153:201–12.
34. Jonuleit H, Kühn U, Müller G, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27:3135–42.
35. Helinski EH, Bielat KL, Ovak GM, et al. Long-term cultivation of functional human macrophages in Teflon dishes with serum-free media. J Leukoc Biol 1988;44:111–21.
36. Akiyama Y, Griffith R, Miller P, et al. Effects of adherence, activation and distinct serum proteins on the in vitro human monocyte maturation process. J Leukoc Biol 1988;43:224–31.